Evidence map›Paper›PMID 33470497›Full record

ArticleStem cells (Dayton, Ohio)2021

Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells.

Swati Mishra, Jasin Taelman, Mina Popovic, Laurentijn Tilleman, Evi Duthoo, Margot van der Jeught, Dieter Deforce, Filip van Nieuwerburgh, Björn Menten, Petra de Sutter and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Germline stem cells in human.Signal transduction and targeted therapy · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Swati MishraGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-6123-8712
Jasin TaelmanGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Mina PopovicGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Laurentijn TillemanLaboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Evi DuthooGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Margot van der JeughtGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Dieter DeforceLaboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Filip van NieuwerburghLaboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-8815-5485
Björn MentenDepartment of Pediatrics and Medical Genetics, Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Petra de SutterGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Annekatrien BoelGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-3256-7020
Susana M Chuva De Sousa LopesGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-3866-2803
Björn HeindryckxGhent-Fertility and Stem cell Team (G-FAST), Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Ghent University Hospital · BEGhent University · BELeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protocols for specifying human primordial germ cell-like cells (hPGCLCs) from human embryonic stem cells (hESCs) remain hindered by differences between hESC lines, their derivation methods, and maintenance culture conditions. This poses significant challenges for establishing reproducible in vitro models of human gametogenesis. Here, we investigated the influence of activin A (ActA) during derivation and maintenance on the propensity of hESCs to differentiate into PGCLCs. We show that continuous ActA supplementation during hESC derivation (from blastocyst until the formation of the post-inner cell mass intermediate [PICMI]) and supplementation (from the first passage of the PICMI onwards) is beneficial to differentiate hESCs to PGCLCs subsequently. Moreover, comparing isogenic primed and naïve states prior to differentiation, we showed that conversion of hESCs to the 4i-state improves differentiation to (TNAP [tissue nonspecific alkaline phosphatase]+/PDPN [podoplanin]+) PGCLCs. Those PGCLCs expressed several germ cell markers, including TFAP2C (transcription factor AP-2 gamma), SOX17 (SRY-box transcription factor 17), and NANOS3 (nanos C2HC-type zinc finger 3), and markers associated with germ cell migration, CXCR4 (C-X-C motif chemokine receptor 4), LAMA4 (laminin subunit alpha 4), ITGA6 (integrin subunit alpha 6), and CDH4 (cadherin 4), suggesting that the large numbers of PGCLCs obtained may be suitable to differentiate further into more mature germ cells. Finally, hESCs derived in the presence of ActA showed higher competence to differentiate to hPGCLC, in particular if transiently converted to the 4i-state. Our work provides insights into the differences in differentiation propensity of hESCs and delivers an optimized protocol to support efficient human germ cell derivation.

Indexed as

ActivinsBlastocystCadherinsCell DifferentiationCells, CulturedGene Expression Regulation, DevelopmentalGerm CellsHuman Embryonic Stem CellsHumansIntegrin alpha6LamininReceptors, CXCR4RNA-Binding ProteinsSignal TransductionSOXF Transcription FactorsTranscription Factor AP-2activin AActivinsCadherinsCXCR4 protein, humanIntegrin alpha6ITGA6 protein, humanLAMA4 protein, humanLamininNANOS3 protein, humanR-cadherinReceptors, CXCR4RNA-Binding ProteinsSOX17 protein, humanSOXF Transcription FactorsTFAP2C protein, humanTranscription Factor AP-2activin A (ActA)differentiationhuman embryonic stem cells (hESCs)pluripotencyprimordial germ cell-like cells (PGCLCs)

Identifiers

PMID33470497
PMCPMC8248136
OpenAlexW3121563009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.